Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | 0.3 | 6e-15 |
mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | 0.27 | 1e-10 |
mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.27 | 1e-09 |
mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.28 | 2e-07 |
mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.2 | 1e-06 |
mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | 0.26 | 1e-05 |
mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | 0.17 | 2e-05 |
mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.16 | 2e-05 |
mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.16 | 2e-05 |
mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | 0.19 | 2e-05 |